PDS Biotech Announces Strategic Refocus Prioritizing PDS0301 in Metastatic Colorectal Cancer (mCRC) and Partnership Strategy for PDS0101

Summary

PDS Biotech announced a strategic refocus prioritizing PDS0301 for metastatic colorectal cancer and pursuing a partnership strategy for PDS0101. The announcement appears to be a corporate strategy update with limited specific clinical or financial details.